SC
Scinai Immunotherapeutics Ltd.
SCNI · NASDAQ
$1.69 -0.59% (-$0.01)
1M -46.01%
Market Cap $208.0
P/E Ratio -
Div. Yield -
ROE 26.63%
Bulios Fair Price
$2.41
42.6% upside
Trenutna cena
$1.69
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SCNI trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.00x
P/S 0.00x
EV/FFO N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 176.62%
Op. margin 562.79%
FCF margin 503.24%
Quality
1 /100
Poor ROE 26.63%
ROA 15.39%
Asset turnover 0.09x
Debt
64 /100
Moderate Current ratio 1.56x
Int. coverage -25.18x
Debt/Equity 0.31x
Stability
1 /100
Unstable EPS volatility 151.55%
Profitable years 0
Beta 2.08x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SCNI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Amir Reichman
Employees
45
Headquarters
Jerusalem
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report